tdm-105795
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 27, 2021 (NCT04913519)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05802173 | Phase 2 | Mar 6, 2023 | Technoderma Medicines Inc., Therapeutics, Inc. |
| NCT05244980 | Phase 1 | Feb 1, 2022 | Technoderma Medicines Inc., Therapeutics, Inc. |
| NCT04913519 | Phase 1 | Apr 27, 2021 | Technoderma Medicines Inc., Therapeutics, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Technoderma Medicines Inc. | For profit | 3 | 3 | 2 | 2021 |
| Therapeutics, Inc. | For profit | 3 | 0 | 2 | 2021 |
2 organizations
Page 1 / 1